Clinton Group’s Charles River Laboratories CRL Stock Holding History

Clinton Group’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$241K	Buy	+1,789	New	+$221K	0.09%	167
2017 Q4	–	Sell	-5,409	Closed	-$584K	–	412
2017 Q3	$584K	Buy	+5,409	New	+$556K	0.06%	273
2017 Q2	–	Sell	-8,458	Closed	-$761K	–	624
2017 Q1	$761K	Buy	8,458 +335	+4%	+$28.5K	0.04%	492
2016 Q4	$619K	Sell	8,123 -34,221	-81%	-$2.6M	0.04%	515
2016 Q3	$3.53M	Buy	42,344 +6,089	+17%	+$510K	0.17%	189
2016 Q2	$2.99M	Buy	36,255 +1,774	+5%	+$146K	0.13%	211
2016 Q1	$2.62M	Buy	+34,481	New	+$2.55M	0.16%	190
2015 Q3	–	Sell	-8,411	Closed	-$592K	–	699
2015 Q2	$592K	Buy	8,411 +3,649	+77%	+$270K	0.08%	346
2015 Q1	$378K	Buy	+4,762	New	+$351K	0.1%	307

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Clinton Group's CRL Position: Q3 2018 in Review

Clinton Group opened a new position in Charles River Laboratories (CRL) in Q3 2018: 1,789 shares worth $241K. The stake represents 0.09% of the portfolio and ranks #167 among its holdings. This is a return to the name: Clinton Group previously reported a position in CRL as recently as Q3 2017.

Clinton Group first reported a position in CRL in Q1 2015 and has held it in 9 quarters since. The position peaked at $3.53M in Q3 2016. 366 funds tracked by Wall St. Rank hold CRL as of Q3 2018.

Clinton Group held 1,789 shares of Charles River Laboratories worth $241K as of Q3 2018.
Charles River Laboratories was a new Clinton Group position in Q3 2018.
Charles River Laboratories made up 0.09% of Clinton Group's portfolio in Q3 2018, its #167 holding.
Clinton Group first reported a position in Charles River Laboratories in Q1 2015 and has held it in 9 quarters since.
Clinton Group's Charles River Laboratories position peaked at $3.53M in Q3 2016.
366 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.